INSIGHTS ON DRUG DEVELOPMENT
-
AAV Full/Empty Capsid Separation Using Mechanistic Modeling
In this study, we used mechanistic modeling to investigate how AAV-resin interactions are affected when MgCl2 is used as an elution additive.
-
Safety, Containment, And Analysis Of Highly Potent Compounds
Explore a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.
-
What Is The FusionOptics Technology?
Learn about stereo microscopes that combine high resolution and depth of field to provide a superior 3D perception of samples.
-
Unlocking The Future: Exploring Cutting-Edge Cell And Gene Therapies
Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches.
-
Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose12/30/2024
Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.
-
The Role Of CRISPR Cas9 Plasmids In Gene-Editing12/12/2023
Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.
-
Unveiling The Biophysics Behind Bio-Layer Interferometry9/27/2024
What is Bio-Layer Interferometry (BLI)? Watch to learn about BLI and the advantages of utilizing a proven BLI platform.
-
The Application Of The Species-Specific Liver-Chip In Predicting Hepatoxicity3/13/2024
An evaluation of 150 drug candidates causing adverse events in humans revealed testing in rats and dogs predicted only 71% of toxicities in humans. Discover a solution to this translational challenge.
-
A New Approach For High-Resolution Full And Empty AAV Capsid Analysis8/14/2023
Review a high-throughput method for comprehensive AAV evaluation utilizing a single CE platform for high-resolution full and empty AAV capsid analysis.
DRUG DEVELOPMENT SOLUTIONS
-
Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.
-
We can assist in the development of necessary validation documents, including test protocols, based on current industry thinking and alignment with global regulatory authority expectations.
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
Discover how our innovative women's health technology enables sustained drug delivery for improved patient outcomes.